ART 446
Alternative Names: ART-446Latest Information Update: 04 Jul 2024
At a glance
- Originator Unknown
- Class Antineoplastics; Small molecules
- Mechanism of Action Checkpoint kinase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours